Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

PFEPfizer Inc.

Healthcare·Drug Manufacturers·NYSE·Mkt cap $160.00B
$24.48
$0.29 (+1.20%) today
IEX feed · not consolidated
Last updated Jul 14, 8:41 PM
53/100 Opportunity
42Risk
48Momentum
51Pullback
36Quality
94Valuation
42Trend
Price & History (up to 5 years)
2025-09-11 → 2026-09-11
Low 22.05— support · — resistanceHigh 29.02
Technical Indicators
RSI (14)46.2
MACD hist0.04
ATR (14)0.52
SMA 2024.63
SMA 5025.35
SMA 20025.30
Rel volume0.9x
Boll upper26.24
Boll lower23.03
52w high28.27
52w low21.98
5y high48.60
5y low19.19
Hist. vol24%
Max drawdown-16%
Long-Term UptrendNeutral MomentumBroken TrendEntry: No Setup
Company QualityWeakening
Revenue growth-30.0%
Earnings growth-40.0%
Profit margin+15.0%
ROE+10.0%
Debt/Equity0.80
Free cash flow$9.00B
P/E16.0
Fwd P/E11.0
P/S2.7
P/B1.6
Div yield+6.2%

Researches, develops, and markets pharmaceuticals and vaccines.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Weak Setup
Opportunity Score
53/100
Risk Level
Moderate
Best Action
Add to watchlist and monitor for confirmation

Why: PFE is trading near recent levels (+1.2% today). Overall, the company shows signs of real business weakness. The long-term trend remains up. Short-term momentum is still weak, so confirmation is needed before acting. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Company guidance weakens further or price loses long-term support on heavy volume.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality36
Historical Context68
Valuation94
Trend42
Momentum48
Pullback51
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward47
Entry Timing25
Sell Risk82
Risk42

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.